NCT00607308 - A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Alzheimer's Disease

Interventions

BIOLOGICAL

PF-04360365

Single dose of 0.1 mg/kg IV on Day 1

BIOLOGICAL

PF-04360365

Single dose of 0.5 mg/kg IV on Day 1

BIOLOGICAL

PF-04360365

Single dose of 1 mg/kg IV on Day 1

BIOLOGICAL

PF-04360365

Single dose of 5 mg/kg IV on Day 1

DRUG

Placebo

Single dose of placebo IV on Day 1

BIOLOGICAL

PF-04360365

Single dose of 10 mg/kg IV on Day 1

Trial Locations (9)

Pfizer Investigational Site, Hirosaki

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Fukuyama

Pfizer Investigational Site, Tsukuba

Pfizer Investigational Site, Kanazawa

Pfizer Investigational Site, Kyoto

Pfizer Investigational Site, Niigata

Pfizer Investigational Site, Bunkyo-ku

Pfizer Investigational Site, Kodaira